Preferred Label : dasabuvir;
CISMeF synonym : ABT-333;
MeSH synonym : N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide;
UNII : DE54EQW8T1;
Origin ID : C588260;
UMLS CUI : C3852512;
Automatic exact mappings (from CISMeF team)
- MeSH term(s) associated for indexing
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
https://www.has-sante.fr/portail/jcms/c_2775799/fr/viekirax-exviera
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
carbamates
antiviral agents
macrocyclic compounds
ritonavir
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
ombitasvir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir
paritaprevir
---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal
product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds
---
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-05-fra.php#mise_%C3%A0_jour
2016
false
false
false
Canada
French
pharmacovigilance note
socioeconomic factors
monograph
cirrhosis of liver, nos
patients
has patient
sectional
indicators
decompensation
administration of medication, nos
effective
drug interactions
disease of liver, nos
observation
drug monitoring
pharmacovigilance
dasabuvir
contraindication to
liver cirrhosis
risk
effect modifier, epidemiologic
drug interaction
hepatic failure, nos
positive
administration
hepatic insufficiency
medication adherence
cirrhosis
monograph
indicators and reagents
observation
drug monitoring
dasabuvir
organization and administration
fibrosis
sulfonamides
uracil
---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil
---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles
---
https://www.ema.europa.eu/medicines/human/EPAR/Exviera
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sulfonamides
sulfonamides
antiviral agents
antiviral agents
drug approval
europe
uracil
adult
hepatitis C, chronic
drug therapy, combination
administration, oral
enzyme inhibitors
enzyme inhibitors
NS-5b protein, hepatitis C virus
NS-5 protein, hepatitis C virus
drug monitoring
product surveillance, postmarketing
risk management
drug interactions
pregnancy
breast feeding
drug resistance, viral
clinical trials as topic
drug evaluation, preclinical
dasabuvir
dasabuvir
dasabuvir
viral nonstructural proteins
dasabuvir
dasabuvir
---
http://www.has-sante.fr/portail/jcms/c_2025737/fr/exviera/viekirax
http://www.has-sante.fr/portail/jcms/c_2025737/fr/viekirax-ombitasvir/paritaprevir/ritonavir-association-fixe-dantiviraux-a-action-directe-exviera-dasabuvir-antiviral-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
anilides
carbamates
carbamates
antiviral agents
antiviral agents
macrocyclic compounds
macrocyclic compounds
ritonavir
ritonavir
sulfonamides
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 4 (organism)
ombitasvir
paritaprevir
dasabuvir
paritaprevir
dasabuvir
ombitasvir, paritaprevir and ritonavir
ombitasvir
dasabuvir
---
Information Update - Risk of Serious Liver Injury associated with Hepatitis C Treatments:
Holkira Pak and Technivie
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/55800a-fra.php
2015
false
false
false
Canada
French
English
Chemical and Drug Induced Liver Injury
pharmacovigilance note
antiviral agents
hepatitis C, chronic
drug combinations
antiviral agents
ombitasvir
paritaprevir
ritonavir
dasabuvir
ombitasvir
dasabuvir
anilides
carbamates
sulfonamides
uracil
uracil
macrocyclic compounds
Contraindications, Drug
---
